Get startedLog in
    Picture of Novartis AG logo

    NOVN — Novartis AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Novartis experimental drug for ALS fails, Bloomberg News reports

    Picture of Novartis AG logoNovartis AG
    16/09/2026 16:13
    Novartis experimental drug for ALS fails, Bloomberg News reports 
    Sept 16 (Reuters) - Novartis NOVN.S halted development of an experimental drug it hoped would treat amyotrophic lateral sclerosis, or Lou Gehrig's disease, Bloomberg News reported on Wednesday. 
    The mid-stage trial was discontinued after the medicine failed to show it worked better than a dummy drug in delaying disease progression, Novartis confirmed in an emailed statement to Bloomberg. 

     (Reporting by Anusha Shah in Bengaluru; Editing by Vijay Kishore)
     ((AnushaDevang.Shah@thomsonreuters.com;))

    Recent news on Novartis AG

    See all news